Corrigendum to "Bortezomib-resistant multiple myeloma patient-derived xenograft is sensitive to anti-CD47 therapy" [Leuk. Res. 122 (2022) 106949].

Leukemia research(2023)

引用 0|浏览11
暂无评分
关键词
xenograft,corrigendum,bortezomib-resistant,patient-derived
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要